PKO Investment Management Joint Stock Co Buys 16,000 Shares of GE HealthCare Technologies Inc. $GEHC

PKO Investment Management Joint Stock Co raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 123.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 29,000 shares of the company’s stock after purchasing an additional 16,000 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in GE HealthCare Technologies were worth $2,178,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Argyle Capital Management LLC raised its holdings in GE HealthCare Technologies by 8.4% in the 3rd quarter. Argyle Capital Management LLC now owns 19,422 shares of the company’s stock worth $1,459,000 after acquiring an additional 1,500 shares during the period. Tokio Marine Asset Management Co. Ltd. grew its position in shares of GE HealthCare Technologies by 3.4% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 15,648 shares of the company’s stock valued at $1,175,000 after purchasing an additional 509 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of GE HealthCare Technologies by 1.7% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,222,704 shares of the company’s stock worth $91,825,000 after purchasing an additional 20,307 shares during the period. First Horizon Corp acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $353,000. Finally, Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at approximately $26,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have commented on GEHC. Citigroup lifted their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Evercore ISI reiterated an “outperform” rating and set a $95.00 target price on shares of GE HealthCare Technologies in a research note on Monday, January 5th. Jefferies Financial Group raised their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Finally, BTIG Research restated a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a report on Friday, November 21st. Seven analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $89.50.

GE HealthCare Technologies Trading Down 0.4%

Shares of GEHC stock opened at $86.90 on Tuesday. The firm has a fifty day moving average of $80.55 and a 200-day moving average of $76.81. The stock has a market cap of $39.58 billion, a price-to-earnings ratio of 17.95, a P/E/G ratio of 3.39 and a beta of 1.08. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter in the previous year, the firm posted $1.14 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.